The pathology group is multidisciplinary and integrates pathologists, hematologists, cytogeneticians and molecular biologists. 

The main goals of the group are:

  • To diagnose and define the morphological, phenotypic, genetic and molecular characteristics of all the tumor samples included in the genome project.
  • To verify and validate in large series of patients the genomic alterations found in the sequencing studies.
  • To determine the pathological implications of the genomic alterations detected in the genomic studies.
  • To characterize the functional implications of the genomic aberrations identified in the genomic studies.